ABSTRACT BACKGROUND Recent studies indicate that Toll-like receptor 4 (TLR4) and myeloid differentiation factor 88 (MyD88)
I mmune cells and their mediators drive the chronic arterial inflammation that is a hallmark of atherosclerosis (1) . Virtually every major immune cell lineage used in host defense has been identified in human and/or animal plaques (1) (2) (3) . Evidence from numerous genetic loss-or gain-of-function studies in animal models shows that immune cell types are generally neither bystanders nor a consequence of plaque development, but instead directly participate in atherogenesis. The array of cytokines that are implicated in atherosclerosis are strikingly similar to those used by immune effector cells to kill foreign pathogens and defective or diseased host cells (1) . Although it is evident that host defense mechanisms play a key role in the development and progression of atherosclerotic disease, it is far less clear how microbial pathogens influence this process.
Toll-like receptors (TLR) are a major mechanism by which the host detects the presence of foreign pathogens and initiates a defensive response (4) (5) (6) . We have identified that TLR4 is a major player in atherosclerosis, which has led to a paradigm shift in the field (7). This was followed by studies that detected the activation of several other TLR in human atherosclerotic plaques as well (8) . Furthermore, previous studies from our lab showed that atherosclerosis-prone mice (17) and adventitia (18, 19) and play an important role in inflammatory vascular disorders such as arteritis (18) (19) (20) (21) . When activated, DC become trapped in the adventitia, local tolerance is broken, and the mature DC can then activate local CD4þ T cells and promote local inflammation (22) . We have previously shown that DC become trapped at sites of plaque development and can no longer maintain tolerization to self, leading to autoimmune mechanisms that trigger inflammation at plaque sites (23) . Besides inducing adaptive immune responses, mature DC also secrete cytokines that recruit immune cells to the site of infection and this requires sufficient TLR stimulation. TLR signaling in DC can also drive regulatory T cells (Treg) (24) . Importantly, Subramanian et al. (25) showed that MyD88 plays a key role in CD11cþ DC (or myeloid cells) by promoting atheroprotective Treg generation and the absence of and atherosclerosis (26) . Indeed, a large body of evidence in mice and humans suggests that the intracellular organism, CP, has been identified in human atherosclerotic plaques (27) (28) (29) and shown to promote progression/exacerbation of atherosclerotic processes, but the molecular mechanisms engaged by CP remain unclear (26, (30) (31) (32) (33) (34) (35) (36) (37) . Live CP (39, 40) and excessive intracellular cholesterol (38) 
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A P R I L 1 0 , 2 0 MICE. All mice were on the C57BL/6 background for these studies. Male and female Apoe -/-and Tlr4
-/-mice were used, but the majority of the animals in each group were male (80% in each group investigated).
ATHEROSCLEROSIS. Mice were fed HFD containing 0.15% cholesterol (Harlan Teklad, Madison, Wisconsin) starting at 8 weeks of age before infection and continuing until sacrifice unless otherwise noted.
Atherosclerosis data were compared between male and female mice. As no significant differences were observed between the sexes, male and female mice were pooled for these studies.
BM CHIMERIC MICE. All mice (both donor and recipients) were on the Apoe -/-background. Eight-weekold recipient mice were irradiated 9.5 Gy (Gammacell Mice were anesthetized with isoflurane before the aorta and the heart were excised. Aortas were dissected from the
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A P R I L 1 0 , 2 0 Briefly, the arrays were incubated in the supernatants and detection antibody cocktail overnight at 4 C.
After washing, the arrays were incubated with streptavidin-horseradish peroxidase and then exposed to the Chemi Reagent Mix. The reaction intensity was analyzed using BioSpectrum UVP Imaging system (Bio-Rad, Hercules, California). 
, despite similar blood cholesterol levels ( Table 1) .
reduction in the atherosclerotic lesion size (25%) and lipid content (30%) in the aortic sinus plaques, compared with control chimeric mice (WT:
led to a significant reduction in lesion size and lipid content that was not significantly different from either deficiency alone (in the hematopoietic or stromal cell compartments). Finally, we also assessed the lesion coverage in the en face aorta preparations and observed a similar reduction ( Figures 1D and 1E ). Similar to the TLR4 chimeras, we generated Myd88
chimeras (all on Apoe -/-background) (Online Figure 1) and observed the effect of its deficiency in
MyD88 Signaling and Atherosclerosis Table 1) . When compared with control mice, as well as significantly less lipid content (36%) in aortic sinus plaques (Figures 2A to 2C ). As before, we found a n ¼ 10 to 12. Data are presented as mean AE SEM. Significance was determined using 2-way analysis of variance with Bonferroni post hoc test (B, C, and E). *p < 0.05, **p < 0.01. TLR4 ¼ Toll-like receptor 4.
MyD88 Signaling and Atherosclerosis reduction in the lesion coverage in en face aorta preparations from both hematopoietic and stromal MyD88-deficient, chimeric mice ( Figures 2D and 2E ).
However, unlike in the aortic root lesions, there was significantly more reduction in the lesion coverage in the en face aorta preparations from mice deficient for n ¼ 7 to 9. Data are presented as mean AE SEM. Significance was determined using 2-way analysis of variance with Bonferroni post hoc test (B, C, and E). *p < 0.05, **p < 0.01. MyD88 ¼ myeloid differentiation factor 88.
MyD88 Signaling and Atherosclerosis MyD88 Signaling and Atherosclerosis We repeated this experiment using Myd88 -/-/Apoe -/-chimeras and found that loss of MyD88 in either stromal or hematopoietic cells also resulted in a failure of CP infection-induced acceleration of atherogenesis ( Figures 6C and 6D) . Additionally, lack of MyD88 in either compartment led to a reduction in circulating IL-6 and IL-12p40 (Online Figure 3) . Thus, CP infection-induced acceleration of atherosclerosis also requires intact TLR4/MyD88 in both hematopoietic and stromal cell components and a lack in either cellular compartment is enough to diminish its effect on acceleration of lesion formation. Significance was determined using 2-way analysis of variance with Bonferroni post hoc test. *p < 0.05; **p < 0.01.
Chen et al. The lifetime pathogen burden is generally considered to play an important role in various chronic inflammatory diseases, including atherosclerosis, but the mechanisms remain unresolved (54, 55) .
Indeed, for some infections such as influenza, vaccination is considered prophylactic for an adverse In the current study, we observed that TLR4 and would. Whereas we did not notice a significant difference at the level of the aortic root, the reduction in lesion coverage in the aorta en face was w50% for total loss of TLR4 ( Figure 1E ) but was almost 80% with total loss of MyD88 ( Figure 2E ). These data suggest that MyD88 plays a larger role in atherosclerosis than just TLR4 signaling.
In this study, we focused on the distal signal from TLR in CP infection-mediated acceleration, and we did not focus on the upstream mechanisms of TLR4.
Our studies show a key role of MyD88, in both stromal 
